Clinical trial
Effect of NGX-4010 on ENFD and Sensory Function
NCT00254449 · NeurogesX, Industry · Completed
Key facts
| NCT number | NCT00254449 |
|---|---|
| Title | Effect of NGX-4010 on ENFD and Sensory Function |
| Official title | A Randomized, Controlled, Open-Label Study to Investigate the Effect of NGX-4010 on Epidermal Nerve Fiber Density and Sensory Function in Healthy Volunteers |
| Lead sponsor | NeurogesX, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Human Volunteers |
| Intervention type | Drug |
| Interventions | NGX-4010 |
| Enrollment | 36 |
| Start date | Nov 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Nov 16, 2005 |
| Last update posted | Feb 16, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: